QIAGEN and Natera to Develop Cutting-Edge Pre-Natal Genetic Testing Assays
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
Third offering in Quest's precision medicine menu for oncology immunotherapies
The company launched the platform at the SynBioBeta 2019 conference in San Francisco
A look at some of the newest generation ‘load and go’ molecular microbiology analyzers
Discover how Mayo Clinic Digital Pathology, powered by NVIDIA and Aignostics, is leveraging AI and vast datasets to revolutionize diagnostics, accelerate medical breakthroughs, and improve patient outcomes worldwide.
A study conducted on artificial 3D tissue models suggests that infections with several pathogens simultaneously increase the risk of cervical cancer
The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO
The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes
New benchtop design and expanded assay portfolio offers researchers greater access to ultra-sensitive Simoa technology for biomarker detection
European launch of the new CE marked ipsogen CALR RGQ PCR Kit to improve MPN diagnosis for leukemia patients, in line with latest WHO recommendations and clinical guidelines
New Products, Articles and Application Notes
Presentation Reviews from the Innovation Academy on ‘Next Generation Diagnostics’
New consumables, software partners, and products for 4D proteomics announced at ASMS 2019